Effect of strontium-containing compounds on bone grafts
Source abstract
Abstract
Biomaterials are biocompatible materials that are used to repair bone defects caused by trauma and bone infections, or bones injured in wars and accidents. Calcium phosphates (CaPs), which have a bioinert structure due to high corrosion resistance and being stable in the body, are the most used biomaterial and considered to be bioactive materials because they are perceived by the body as its tissue and have an accelerating healing effect. CaPs are used extensively for hard- and soft-tissue applications in medicine because of their elemental composition, high level of similarity to the minerals in bone and teeth, and high biocompatibility within the body. However, due to low fracture toughness values or poor mechanical properties of CaPs, different additives like strontium (Sr) and its compounds are added into them to improve their properties. Especially in recent years, it has become an important purpose and field of study to produce more economical alternative CaPs-based, as well as Sr- and its compounds-added biocompatible bone grafts and implant materials having enhanced microstructure and mechanical properties. Sr and its compounds that improve the mechanical properties of CaP compounds have been indicated as an impressive stimulant for bone repair and new bone formation. Sr2+ ion (Sr ranelate), which is used as a drug, especially in osteoporosis disorders, reveals biocompatibility and also increases bone fracture repair. This review explains the literature on the morphological and mechanical properties of CaP-based Sr compounds, which have been added into various CaP-based bone grafts or used as implant coating on bone grafts. Also, biocompatibility studies on bone grafts containing Sr are explained, and it is aimed to contribute to the studies done in this area.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Wnek G, Bowlin GL (2008) Encyclopedia of biomaterials and biomedical engineering, 2nd edn. Marcel Dekker, New York
2. Ozalp Y, Özdemir N (1996) Biyomateryaller ve biyouyumluluk. Ankara Universitesi Eczacılık Fakultesi Dergisi 25:57–7210.1501/Eczfak_0000000307 ↗
3. Tirrell M, Efrosini K, Markus B (2002) The role of surface science in bioengineered materials. Surf Sci 500:61–8310.1016/S0039-6028(01)01548-5 ↗
4. Lu J, Descamps M, Dejou J, Koubi G, Hardouin P, Lemaitre J, Proust JP (2002) The biodegradation mechanism of calcium phosphate biomaterials in bone. J Biomed Mater Res A 63:408–41210.1002/jbm.10259 ↗
5. Khan AF, Saleem M, Afzal A, Ali A, Khan A, Khan AR (2014) Bioactive behavior of silicon substituted calcium phosphate based bioceramics for bone regeneration. Mater Sci Eng C Mater 35:245–25210.1016/j.msec.2013.11.013 ↗
6. Suchanek W, Yoshimura M (1998) Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 13:94–11710.1557/JMR.1998.0015 ↗
7. Murugan R, Ramakrishna S (2005) Development of nanocomposites for bone grafting. Compos Sci Technol 65:2385–240610.1016/j.compscitech.2005.07.022 ↗
8. Surmenev RA, Shkarina S, Syromotina DS et al (2019) Characterization of biomimetic silicate-and strontium-containing hydroxyapatite microparticles embedded in biodegradable electrospun polycaprolactone scaffolds for bone regeneration. Eur Polym J 113:67–7710.1016/j.eurpolymj.2019.01.042 ↗
9. Gökçek EI (2006) Ortopedik implant ve protez tasarımı için biyomalzemelerin mekanik özelliklerinin araştırılması. M.Sc. Dissertation, University of Zonguldak Karaelmas
10. Oztuna V, Yilmaz A, Yilmaz C, Eskandari MM, Ayan I, Milcan A, Kuyurtar F (2005) The use of N-butyl-2-cyanoacrylate (Histoacryl) in primary tendon repair: a biomechanical study with sheep flexor tendons. Acta Orthop Traumato 39:258–262
11. Rho JY, Kuhn-Spearing L, Zioupos P (1998) Mechanical properties and the hierarchical structure of bone. Med Eng Phys 20:92–10210.1016/S1350-4533(98)00007-1 ↗
12. Park J, Lakes RS (2007) Biomaterials: an introduction, 3rd edn. Springer, New York
13. Mow C, Hayes V, Wilson C (1991) Basic orthapaedic biomechanics, 1st edn. Raven Press, New York
14. Nordin M, Frankel HV (1989) Basic biomechanics of the musculoskeletal system, 3rd edn. Lippincott W & Wilkins, Philadelphia
15. Terrier A (1999) Adaptation of bone to mechanical stress, theoretical model, experimental identification and orthopedic applications. Ph.D. Dissertation, Zurich: Swiss Federal Institute of Technology
16. Ozkoc G (2008) Doku muhendisligi ve doku muhendisligi uygulamalarında biyomalzemeler, yapı iskeleleri ve biyoreaktorler, Temel Kok Hücre Teknikleri ve Molekuler Biyoloji Uygulamaları Kurs Kitapçığı. Report for Kok Hucre ve Gen Tedavileri Araştırma ve Uygulama Merkezi, Course Book, Kocaeli University
17. Evans FG (1973) Mechanical properties of bone, 1st edn. Thomas Pub, Christopher
18. Sikavitsas VI, Temenoff JS, Mikos AG (2001) Biomaterials and bone mechanotransduction. Biomaterials 22:2581–259310.1016/S0142-9612(01)00002-3 ↗
19. Doblare M, Garcia JM, Gomez MJ (2004) Modelling bone tissue fracture and healing: a review. Eng Fract Mech 71:1809–184010.1016/j.engfracmech.2003.08.003 ↗
20. Beskardes IG (2008) Biyoseramik ve biyosinyal molekullerle desteklenmis poli(kaprolakton) doku iskeleleri: sentez, karakterizasyon ve mekanik doku muhendisligi uygulamaları. M.Sc. Dissertation, Hacettepe University
21. Park YJ, Hwang KS, Song JE, Ong JL, Rawls HR (2002) Growth of calcium phosphate on poling treated ferroelectric BaTiO3 ceramics. Biomaterials 23:3859–386410.1016/S0142-9612(02)00123-0 ↗
22. Akdogan G (1998) Ti–6Al–4V Alasımının Biyokorozyon ve Biyouyumluluk Özelliklerinin Arastırılması. Ph.D. Dissertation, Gazi University
23. Hench LL, Splinter RJ, Allen WC, Greenlee TK (1971) Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res A 2:117–14110.1002/jbm.820050611 ↗
24. Hench LL (1991) Bioceramics: from concept to clinic. J Am Ceram Soc 74:1487–151010.1111/j.1151-2916.1991.tb07132.x ↗
25. Hench LL (1998) Bioactive materials: the potential for tissue engineering. J Biomed Mater Res 41:511–51810.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F ↗
26. Bronzino JD, Park JB (2003) Biomaterials principles and applications, 1st edn. CRC Press, New York
27. Jenkins M (2007) Biomedical polymers, 1st edn. CRC Press, New York10.1201/9781439823972 ↗
28. Nair LS, Laurencin CT (2007) Biodegradable polymers as biomaterials. Prog Polym Sci 32:762–79810.1016/j.progpolymsci.2007.05.017 ↗
29. Fuh LJ, Huang YJ, Chen WC, Lin DJ (2017) Preparation of micro-porous bioceramic containing silicon-substituted hydroxyapatite and beta-tricalcium phosphate. Mater Sci Eng C Mater 75:798–80610.1016/j.msec.2017.02.065 ↗
30. Dimitriou R, Jones E, McGonagle D, Giannoudis PV (2011) Bone regeneration: current concepts and future directions. BMC Med 9:66–7610.1186/1741-7015-9-66 ↗
31. Campana V, Milano G, Pagano E et al (2014) Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med 25:2445–246110.1007/s10856-014-5240-2 ↗
32. Wang W, Yeung KW (2017) Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact Mater 2:224–24710.1016/j.bioactmat.2017.05.007 ↗
33. Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM (2005) The biology of bone grafting. J Am Acad Orthop Surg 13:77–8610.5435/00124635-200501000-00010 ↗
34. Albrektsson T, Johansson C (2001) Osteoinduction, osteoconduction and osseointegration. Eur Spine J 10:96–10110.1007/s005860100282 ↗
35. Oztopalan DF (2017) Kemik Greftleri ve Veteriner Ortopedide Kullanımı. Dicle Üniversitesi Veteriner Fakültesi Dergisi 10:76–82
36. Bauer TW, Muschler GF (2000) Bone graft materials: an overview of the basic science. Clin Orthop Relat Res 371:10–2710.1097/00003086-200002000-00003 ↗
37. Roberts TT, Rosenbaum AJ (2012) Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing. Organogenesis 8:114–12410.4161/org.23306 ↗
38. Zwingenberger S, Nich C, Valladares RD, Yao Z, Stiehler M, Goodman SB (2012) Recommendations and considerations for the use of biologics in orthopedic surgery. BioDrugs 26:245–25610.1007/BF03261883 ↗
39. Yamamuro T, Hench LL, Wilson J (1990) Handbook of bioactive ceramics: Ca-P and HA ceramics, 2nd edn. CRC Press, Bato Raton
40. Yetkin H (2001) Ortopedi ve Travmatolojide Biomateryaller. In: 8th Biomedical Science and Technology Symposium (BİOMED8), Ankara, 5–8 September 2001
41. Bajpai PK, Fuchs CM (1985) Development of a hydroxyapatite bone grout. In: Proceedings of the first annual scientific session of the academy of surgical research. Pergamon Press, New York
42. Jiménez M, Abradelo C, Román JS, Rojo L (2019) Bibliographic review on the state of the art of strontium and zinc based regenerative therapies. Recent developments and clinical applications. J Mater Chem B 7:1974–198510.1039/C8TB02738B ↗
43. Xiao S, Wang M, Wang L, Zhu Y (2018) Environment-friendly synthesis of trace element Zn, Sr, and F codoping hydroxyapatite with non-cytotoxicity and improved osteoblast proliferation and differentiation. Biol Trace Elem Res 185:148–16110.1007/s12011-017-1226-5 ↗
44. Enderle R, Götz-Neunhoeffer F, Göbbels M, Müller FA, Greil P (2005) Influence of magnesium doping on the phase transformation temperature of β-TCP ceramics examined by Rietveld refinement. Biomaterials 26:3379–338410.1016/j.biomaterials.2004.09.017 ↗
45. Turkyilmaz I (2011) Implant dentistry—the most promising discipline of dentistry, 1st edn. InTech, Rijeka10.5772/964 ↗
46. Albee FH (1920) Studies in bone growth: triple calcium phosphate as a stimulus to osteogenesis. Ann Surg 71:32–3910.1097/00000658-192001000-00006 ↗
47. Bhatt RA, Rozental TD (2012) Bone graft substitutes. Hand Clin 28:457–46810.1016/j.hcl.2012.08.001 ↗
48. Ogose A, Kondo N, Umezu H et al (2006) Histological assessment in grafts of highly purified beta-tricalcium phosphate (OSferion®) in human bones. Biomaterials 27:1542–154910.1016/j.biomaterials.2005.08.034 ↗
49. Buchanan FJ (2008) Degradation rate of bioresorbable materials: prediction and evaluation, 1st edn. CRC Press, New York10.1533/9781845695033 ↗
50. Bohner M (2001) Physical and chemical aspects of calcium phosphates used in spinal surgery. Eur Spine J 10:114–12110.1007/s005860100250 ↗
51. Finkemeier CG (2002) Bone-grafting and bone-graft substitutes. J Bone Joint Surg 84(3):454–46410.2106/00004623-200203000-00020 ↗
52. Ducheyne P (2011) Comprehensive biomaterials, 1st edn. Elsevier, Oxford
53. Ravarian R, Moztarzadeh F, Hashjin MS, Rabiee SM, Khoshakhlagh P, Tahriri M (2010) Synthesis, characterization and bioactivity investigation of bioglass/hydroxyapatite composite. Ceram Int 36:291–29710.1016/j.ceramint.2009.09.016 ↗
54. Ryu HS, Hong KS, Lee JK et al (2004) Magnesia-doped HA/β-TCP ceramics and evaluation of their biocompatibility. Biomaterials 25:393–40110.1016/S0142-9612(03)00538-6 ↗
55. Bose S, Tarafder S, Banerjee SS, Davies NM, Bandyopadhyay A (2011) Understanding in vivo response and mechanical property variation in MgO, SrO and SiO2 doped β-TCP. Bone 48:1282–129010.1016/j.bone.2011.03.685 ↗
56. Banerjee SS, Tarafder S, Davies NM, Bandyopadhyay A, Bose S (2010) Understanding the influence of MgO and SrO binary doping on the mechanical and biological properties of β-TCP ceramics. Acta Biomater 6:4167–417410.1016/j.actbio.2010.05.012 ↗
57. Bohner M (2009) Silicon-substituted calcium phosphates—a critical view. Biomaterials 30:6403–640610.1016/j.biomaterials.2009.08.007 ↗
58. Sheldon EA, King AJ (1953) Structure of the allotropic forms of strontium. Acta Crystallogr 6:10010.1107/S0365110X53000302 ↗
59. Nielsen SP (2004) The biological role of strontium. Bone 35(3):583–58810.1016/j.bone.2004.04.026 ↗
60. Querido W, Rossi AL, Farina M (2016) The effects of strontium on bone mineral: a review on current knowledge and microanalytical approaches. Micron 80:122–13410.1016/j.micron.2015.10.006 ↗
61. Bigi A, Boanini E, Capuccini C, Gazzano M (2007) Strontium-substituted hydroxyapatite nanocrystals. Inorg Chim Acta 360:1009–101610.1016/j.ica.2006.07.074 ↗
62. Christoffersen J, Christoffersen MR, Kolthoff N, Bärenholdt O (1997) Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detection. Bone 20:47–5410.1016/S8756-3282(96)00316-X ↗
63. Geng Z, Cui Z, Li Z et al (2016) Strontium incorporation to optimize the antibacterial and biological characteristics of silver-substituted hydroxyapatite coating. Mater Sci Eng C Mater 58:467–47710.1016/j.msec.2015.08.061 ↗
64. Tovani CB, Oliveira TM, Gloter A, Ramos AP (2018) Sr2+-substituted CaCO3 nanorods: impact on the structure and bioactivity. Cryst Growth Des 18:2932–294010.1021/acs.cgd.8b00017 ↗
65. Pilmane M, Salma-Ancane K, Loca D, Locs J, Berzina-Cimdina L (2017) Strontium and strontium ranelate: historical review of some of their functions. Mater Sci Eng C Mater 78:1222–123010.1016/j.msec.2017.05.042 ↗
66. Zhang M, Lin K, Chang J (2012) Preparation and characterization of Sr–hardystonite (Sr2ZnSi2O7) for bone repair applications. Mater Sci Eng C Mater 32:184–18810.1016/j.msec.2011.10.017 ↗
67. Yantao Z, Jun Y, Dagang G, Shuxun H, Ying Z, Chunli Z, Hongbin Z (2014) Doping of strontium into natural bone powder and further cell experiment. Rare Met Mater Eng 43:2980–298410.1016/S1875-5372(15)60046-7 ↗
68. Kavitha RJ, Ravichandran K, Narayanan TS (2018) Deposition of strontium phosphate coatings on magnesium by hydrothermal treatment: characteristics, corrosion resistance and bioactivity. J Alloys Compd 745:725–74310.1016/j.jallcom.2018.02.200 ↗
69. Marie PJ, Felsenberg D, Brandi ML (2011) How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporosis Int 22:1659–166710.1007/s00198-010-1369-0 ↗
70. Grynpas MD, Hamilton E, Cheung R, Tsouderos Y, Deloffre P, Hott M, Marie PJ (1996) Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone 18:253–25910.1016/8756-3282(95)00484-X ↗
71. Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42:129–13810.1016/j.bone.2007.08.043 ↗
72. Yang F, Yang D, Tu J, Zheng Q, Cai L, Wang L (2011) Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling. Stem Cells 29:981–99110.1002/stem.646 ↗
73. Peng S, Liu XS, Huang S et al (2011) The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Bone 49:1290–129810.1016/j.bone.2011.08.031 ↗
74. Neves N, Campos BB, Almeida IF, Costa PC, Cabral AT, Barbosa MA, Ribeiro CC (2016) Strontium-rich injectable hybrid system for bone regeneration. Mater Sci Eng C Mater 59:818–82710.1016/j.msec.2015.10.038 ↗
75. Schumacher M, Henß A, Rohnke M et al (2013) A novel and easy-to-prepare strontium(II) modified calcium phosphate bone cement with enhanced mechanical properties. Acta Biomater 9:7536–754410.1016/j.actbio.2013.03.014 ↗
76. Boanini E, Torricelli P, Gazzano M, Gelinsky M (2014) Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses. Biomaterials 35:5619–562610.1016/j.biomaterials.2014.03.053 ↗
77. Suganthi RV, Elayaraja K, Joshy MA, Chandra VS, Girija EK, Kalkura SN (2011) Fibrous growth of strontium substituted hydroxyapatite and its drug release. Mater Sci Eng C Mater 31:593–59910.1016/j.msec.2010.11.025 ↗
78. Geng Z, Wang R, Zhuo X et al (2017) Incorporation of silver and strontium in hydroxyapatite coating on titanium surface for enhanced antibacterial and biological properties. Mater Sci Eng C Mater 71:852–86110.1016/j.msec.2016.10.079 ↗
79. Kruppke B, Wagner AS, Rohnke M et al (2019) Biomaterial based treatment of osteoclastic/osteoblastic cell imbalance—gelatin-modified calcium/strontium phosphates. Mater Sci Eng C Mater 104:10993310.1016/j.msec.2019.109933 ↗
80. Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcified Tissue Int 69:121–12910.1007/s002230010055 ↗
81. Peng S, Liu XS, Wang T et al (2010) In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells. J Orthop Res 28:1208–121410.1002/jor.21127 ↗
82. Bain SD, Jerome C, Shen V, Dupin-Roger I, Ammann P (2009) Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporosis Int 20:1417–142810.1007/s00198-008-0815-8 ↗
83. Curtis EM, Moon RJ, Dennison EM, Harvey NC, Cooper C (2015) Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med 15:92–9610.7861/clinmedicine.15-6-s92 ↗
84. Marie PJ (2010) Osteoporosis: a disease of bone formation. Medicographia 32:10–17
85. Thormann U, Ray S, Sommer U et al (2013) Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. Biomaterials 34:8589–859810.1016/j.biomaterials.2013.07.036 ↗
86. Furkó M, Balázsi K, Balázsi C (2017) Comparative study on preparation and characterization of bioactive coatings for biomedical applications—a review on recent patents and literature. Rev Adv Mater Sci 48:25–51
87. Dorozhkin SV (2010) Bioceramics of calcium orthophosphates. Biomaterials 31:1465–148510.1016/j.biomaterials.2009.11.050 ↗
88. Combes C, Rey C (2010) Amorphous calcium phosphates: synthesis, properties and uses in biomaterials. Acta Biomater 6:3362–337810.1016/j.actbio.2010.02.017 ↗
89. Bridwell KH, O’brien MF, Lenke LG, Baldus C, Blanke K (1994) Posterior spinal fusion supplemented with only allograft bone in paralytic scoliosis. Does it work? Spine 19:2658–266610.1097/00007632-199412000-00011 ↗
90. Keating JF, McQueen MM (2001) Substitutes for autologous bone graft in orthopaedic trauma. Bone Joint J 83:3–810.1302/0301-620X.83B1.0830003 ↗
91. Zimmermann G, Moghaddam A (2011) Allograft bone matrix versus synthetic bone graft substitutes. Injury 42:16–2110.1016/j.injury.2011.06.199 ↗
92. Reginster JY, Seeman E, De Vernejoul MC et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocr Metab 90:2816–282210.1210/jc.2004-1774 ↗
93. Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:4–910.1016/j.bone.2005.11.024 ↗
94. Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New Engl J Med 350:459–46810.1056/NEJMoa022436 ↗
95. Marie PJ (2007) Strontium ranelate: new insights into its dual mode of action. Bone 40:5–810.1016/j.bone.2007.02.003 ↗
96. Reginster JY, Neuprez A, Dardenne N, Beaudart C, Emonts P, Bruyere O (2014) Efficacy and safety of currently marketed anti-osteoporosis medications. Best Pract Res Clin Endocr Metab 28:809–83410.1016/j.beem.2014.09.003 ↗
97. Ratnayake JT, Mucalo M, Dias GJ (2017) Substituted hydroxyapatites for bone regeneration: a review of current trends. J Biomed Mater Res B 105:1285–129910.1002/jbm.b.33651 ↗
98. Liu M, Zhang F, Wang P, Ming J, Zuo B (2017) Preparation and characterization of silk fibroin/strontium carbonate film through rapid formation. Mater Lett 189:46–4910.1016/j.matlet.2016.11.048 ↗
99. Moreira APD, Sader MS, Soares GDDA, Leão MHMR (2014) Strontium incorporation on microspheres of alginate/β-tricalcium phosphate as delivery matrices. Mater Res 17:967–97310.1590/S1516-14392014005000095 ↗
100. Cadar O, Balint R, Tomoaia G et al (2017) Behavior of multisubstituted hydroxyapatites in water and simulated body fluid. Stud Univ Babes-Bol Chem 62:269–281